20 10, 10, the world authoritative nattokinase organization-Japan nattokinase association and the patent owner of nattokinase-Japan Institute of Life Sciences invited China National Medical Education Development Center to hold a press conference in Beijing Media Center, and issued a statement: Japan Institute of Life Sciences is the largest nattokinase raw material manufacturer in Japan and even the world. Is the only one with the patent of nattokinase production (patent No.388 granted by Japan Patent Office). The nattokinase developed in this study is produced by fermentation of Bacillus natto culture solution and extracted and purified by special technology and process. The high-purity nattokinase product made of this material has the function of dissolving thrombus and is a high-tech product in the field of modern biology. Its safety and effectiveness have been verified by medical clinic and fully recognized by Japan Nattokinase Association.
According to the statement, although Professor Nishimoto of Japan is the discoverer of the thrombolytic effect of nattokinase, he himself has no right to authorize the production enterprises to produce nattokinase. The production of nattokinase by any enterprise or individual except Japan Institute of Life Sciences may involve infringement of the product patents and legitimate rights and interests of the institute. In addition, the standard unit of nattokinase products formulated by Japan's official health and nutrition food association is "FU", not "IU".